PhD student in the Matter and ChemCognition labs @UofT, @EPFL alumni 👩🏽‍🔬 • AI enthusiast @VectorInst 👩🏽‍💻

Toronto, ON, Canada
Joined May 2020
Ella Rajaonson retweeted
Introducing SelectBench, the first benchmark to evaluate conditional generative models of molecules in a context of selectivity.
A molecule can bind the right protein and still be the wrong drug. Why? Because it might also bind proteins we don't want it to, potentially causing serious side effects. 📄 Paper: arxiv.org/abs/2610.24124
3
27
1,782
Ella Rajaonson retweeted
Generating proteins -> ??? -> Testing them in the lab The missing piece is SELECTBENCH – evaluating your generations before sending them to the lab - We design metrics to evaluate your model on the selectivity task - We collect three datasets of ON/OFF targets from different sources and of different difficulty levels - We study how modern generative models perform on these tasks (far from perfect) - With SELECTBENCH, the question of generating proteins becomes the question of the throughput of your model! - Check it out at #neurips2026 and benchmark your model using the code from github.com/lovetaro/selectbe… This is one of the links in our long chain of works on generating selective proteins (see my slides for the synthesis docs.google.com/presentation…)
A molecule can bind the right protein and still be the wrong drug. Why? Because it might also bind proteins we don't want it to, potentially causing serious side effects. 📄 Paper: arxiv.org/abs/2610.24124
2
18
129
5,609
Ella Rajaonson retweeted
Binding is good. Selective binding is better. 🧬 Super hyped to share SelectBench, evaluating selectivity in generative drug design, has been accepted to the NeurIPS 2026! 🎉 Huge shoutout to amazing @ERajaonson and all my collaborators who made this happen ❤️
A molecule can bind the right protein and still be the wrong drug. Why? Because it might also bind proteins we don't want it to, potentially causing serious side effects. 📄 Paper: arxiv.org/abs/2610.24124
1
2
17
1,752
A molecule can bind the right protein and still be the wrong drug. Why? Because it might also bind proteins we don't want it to, potentially causing serious side effects. 📄 Paper: arxiv.org/abs/2610.24124
6
24
4
107
12,773
The takeaway? Selectivity is far from solved. Even selectivity-aware models struggle, and inference-time guidance can help, but its improvements remain limited. We hope SelectBench helps close this gap and motivates future work on selective molecular design.
1
4
193
📄 Paper: arxiv.org/abs/2610.24124 💻 Code & benchmark: github.com/lovetaro/selectbe… Thanks again to all my collaborators, especially @yololulu_ for co-leading this work! William Chau @A_Aspuru_Guzik Benjamin Sanchez-Lengeling @dom_beaini @k_neklyudov @martoskreto
8
233
Ella Rajaonson retweeted
Check out our IGLOO 🧊 preprint!
Do protein representations encode variant function? Diagnosing residue-level protein attributions via embedding-space gradients 1. The paper introduces IGLOO, a benchmarking framework to test whether residue-level attributions (via Integrated Gradients on protein language model embeddings) actually recover functionally important residues, rather than merely producing plausible-looking heatmaps. 2. IGLOO’s core idea is to create synthetic fitness landscapes where per-residue “ground-truth importance” is known, enabling direct scoring of attribution fidelity. It builds 9 protein–landscape settings using 3 proteins (GB1, T4 lysozyme, p53) × 3 landscape types (additive, epistatic, nonlinear “cliff”), and systematically sweeps label noise to decouple accuracy from interpretability. 3. A central finding: predictive accuracy (held-out Spearman correlation on fitness) weakly tracks attribution quality. Models can predict variant fitness well while producing residue attributions that are near-random relative to known important sites—an explicit demonstration of the prediction–explanation fallacy in pLM-based variant effect prediction. 4. The work diagnoses why this happens using cascading parameter randomization: in common “pool-first” architectures (attention pooling on per-residue embeddings before the MLP head), attributions barely change when randomizing most of the predictor head, but collapse when randomizing the pooling layer—showing the pooling module largely determines residue-level attribution patterns. 5. A practical architectural intervention improves attribution: moving learned computation before pooling (“pool-later” via per-residue processing + pooling) substantially strengthens the link between model learning and residue attributions. In one example (GB1 additive), the correlation between attribution quality and predictive accuracy increases dramatically (Pearson r from 0.23 to 0.83). 6. Backbone choice matters for interpretability: across seven pLMs from ESM-C, Profluent E1, and Ankh families, Ankh models yield the most consistent attribution quality across landscapes, and bigger is not always better (Ankh-base can outperform Ankh-large). 7. Intermediate layers can predict “well” but attribute poorly: for Ankh-base, attribution quality collapses when using intermediate hidden states (even when prediction Spearman can reach ~0.6), while final-layer representations give the best attribution. The paper argues this may relate to scaling/normalization properties of intermediate residual streams. 8. Ensembling improves stability of interpretability: averaging attributions across independently seeded predictor heads reduces attribution variance roughly at the expected 1/sqrt(K) rate, making residue-level interpretations more reliable without major added cost. 9. Real-protein case studies mirror synthetic conclusions. On FLIP2 α-amylase splits, the split with best predictive performance does not necessarily yield best recovery of annotated functional categories; pool-later heads outperform pool-first heads for attribution across splits. On TEM-1 β-lactamase datasets, top-attributed sites show partial agreement with known functional residues, and in silico checks (stability and binding proxies) match attribution sign in ~2/3 of tested mutant–ligand combinations. 💻Code: github.com/chemcognition-lab… 📜Paper: biorxiv.org/content/10.64898… #ProteinEngineering #ProteinLanguageModels #Interpretability #IntegratedGradients #DeepLearning #ComputationalBiology #MachineLearning #VariantEffectPrediction
1
2
5
273
Ella Rajaonson retweeted
Are chemists done & is NMR solved? Not so fast! 🤔 Outperforming software is not the goal, to be truly useful, AI needs to operate like a human chemist under real lab conditions. ✨Check our #ICML2026 AI4Science Spotlight! 🔗OpenReview: openreview.net/forum?id=hsfH… Thread 🧵 (1/7)
New Anthropic Science Blog: Making Claude a chemist. To manipulate a molecule, chemists first need to understand its structure. Their main tool is NMR spectroscopy. We found Opus 4.7 matches—and on some tasks beats—dedicated NMR software. Read more: anthropic.com/research/makin…
1
10
1
19
4,731
Ella Rajaonson retweeted
Feynman-Kac Correctors back in action 😎 -- this time for steering protein generation towards (1) multimodal rewards that require both sequence and structure information and (2) specificity (predicted binding to an on-target but not an off-target). This is only one small mirror on the DISCO 🪩 ball -- our new model to co-design generate protein sequences and structures around arbitrary biomolecules (no inverse folding needed!). Check out the thread below to see everything you can generate with our model, including tips n tricks for inference (turns out these make a huge difference), and, most importantly, super cool wet lab results!!! 🧪 Super proud of the whole team (special shoutout to @jarridrb, @ChengHaoLiu1, @k_neklyudov, @AlexanderTong7), this was a huge effort. 🫶
What if AI could invent enzymes that nature hasn’t seen? 👩‍🔬🧑‍🔬 Introducing 🪩 DISCO: Diffusion for Sequence-structure CO-design 14 rounds of directed evolution and over a year of wet lab work. That's what it took to engineer an enzyme for selective C(sp³)–H insertion, one of the most challenging transformations in organic chemistry. DISCO surpasses this with a single plate. No pre-specified catalytic residues, no template, no theozyme, no inverse folding, just joint diffusion over protein sequence and structure. 📝 Blog: disco-design.github.io/ 📄 Paper: arxiv.org/abs/2604.05181 💻 Code: github.com/DISCO-design/DISC…
9
56
6,438
Ella Rajaonson retweeted
The news is out! We're starting Blank Bio to build a computational toolkit assisted with RNA foundation models. If you want to see my flip between being eerily still and overly animated check out the video below! The core hypothesis is that RNA is the most customizable molecule in the world. It's fast to produce, inherently programmable, and highly adaptable to diverse use cases. It's an open secret amongst folks who've worked at Deep Genomics, and that's why almost everyone is still working on RNA applications. We're building out the next generation of tooling enabled by our foundation models and partnering with companies to accelerate their work. If you have a use-case big or small we'd love to chat, please reach out. The foundation models we're building stem from intuition acquired through years of research from our PhDs. We learned that effective biological models require deep understanding of data, specific architectures and loss functions that reflect the molecular processes shaping the data. Genomics metrics like conservation and constraint inform model development. One of the best parts about this is that I get to work with such talanted, kind, ambitious people. @hsu_jonny has spent the last five years defining what great ML+Bio products look like and consistently pushes us to adapt to customer needs with mission oriented clarity. @ianshi3 is the most thoughtful and creative scientist I've ever worked with, bringing a great sense of design to everything he does. We're on a mission to build something great and useful for RNA scientists around the world. blank dot bio
Blank Bio (@blankbio_) is building foundation models to power a computational toolkit for RNA therapeutics, starting with mRNA design and expanding to target ID, biomarker discovery, and more. ycombinator.com/launches/O8Z… Congrats on the launch, @hsu_jonny, @phil_fradkin & @ianshi3!
13
23
3
173
21,157
Ella Rajaonson retweeted
AI4Mat is back for NeurIPS! time to crystallize those ideas and make a solid-state submission by august 22, 2025 💪 new this year: opt-in your work for our Research Learning from Speaker Feedback program -- a new structured discussion format where spotlight presenters receive curated, in-depth feedback from invited discussants 🧐 check out our website for more: sites.google.com/view/ai4mat… brought to you by a 🔥organizing committee: @MiretSantiago @anoopnm007 @SteMartiniani @kmjablonka @ADuvalinho Emily Jin Rocío Mercado Oropeza
20
1
83
7,017
I will be at #NeurIPS next week, presenting work on Bayesian Optimization over curried functions at the AI4Mat workshop. We use it to identify general reaction conditions neurips.cc/virtual/2024/1037… If you are around and interested in talking #BayesOpt or #AI4Science, let’s meet
3
5
489
Is there enough public data in AI4bio to repeat the success of LLMs in NLP? Not clear. What is clear is that we aren’t even using all the available tokens. Our new preprint: often-ignored text tokens can improve protein LMs. 🤗tinyurl.com/yx6cccnw 📝tinyurl.com/3a49epbx
1
17
2
61
14,668